Disturbances of one-carbon metabolism in neuropsychiatric disorders. A review

Biological Psychiatry

Volumn 41, Issue 2, 1997, Pages 230-233

  Smythies, John R ^a,b   Gottfries, Carl Gerhard ^c   Regland, Björn ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

aminochromes; homocysteine; methionine adenosyl transferase; neuromelanin; schizophrenia; transmethylation

Indexed keywords

CARBON;

BRAIN METABOLISM; HUMAN; NEUROPSYCHIATRY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

EID: 0031057859     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00068-6     Document Type: Review

References (37)

1. Akil M. & Lewis DA (1995): The catecholaminergic innervation of the human entorhinal cortex: Alteration in schizophrenia. Abst Soc Neurosci 21:238.
2. Antun FT, Burnett GB, Cooper AJ, Daly RJ, Smythies JR, Zealley AK (1971): The effects of 1-methionine (without MAOI) in schizophrenia. J Psychiatr Res 8:63-71.
3. Aroca, P, Solano F, Saunas C, García-Borrón JC, Lozano JA (1992): Regulation of the final phase of mammalian melanogenesis. Eur J Biochem 208:155-163.
4. Axelrod J (1964): Enzymic oxidation of epinephrine to adrenochrome by the salivary gland. Biochim Biophys Acta 85:247-254.
5. Bressa GM (1994): S-adenosyl-l-methionine (SAMe) as antide-pressant: Meta-analysis of clinical studies. Acta Neurol Scand Suppl. 154:7-14.
6. Carlsson A, Waters N, Hansson LO (1995): Neurotransmitter aberrations in schizophrenia: New findings. In Fog R, Gerlach J, Hemmingsen R (eds), Schizophrenia. An Integrated View. Proceedings of a symposium held at the Royal Danish Academy of Sciences and Letters, 5-9 June 1994, Copenhagen: Munksgard, pp. 332-343.
7. Carstam R, Brinck C, Hindemith-Augustsson A, Rorsman H, Rosengren E (1991): The neuromelanin of the human substantia nigra. Biochim Biophys Acta 1097:152-160.
8. Garey LJ, Ong UY, Patel TS, Kanami M, Davis A, Hornstein C, Bauer M (1995): Reduction in dendritic spine number on cortical neurons in schizophrenia. Abst Soc Neurosci 21:236.
9. Geiger R (1960): Effects of LSD-25, serotonin and sera from schizophrenic patients on adult mammalian brain cultures. J Neuropsychiatry 1:185-199.
10. Glantz LA, Lewis DA (1995): Assessment of spine density on layer III pyramidal cells in the prefrontal cortex of schizophrenic subjects. Abst Soc Neurosci 21:239.
11. Gomes-Trolin (1996): Ph.D. Thesis presented at Uppsala University, 1996.
12. Gomes-Trolin C, Regland B, Oreland L (1995): Decreased methionine adenosyltransferase in erythrocytes of patients with dementia disorders. Eur J Neuropsychopharmacol 5:107-114.
13. Goodwin F, Shafritz D, Weissbach H (1969): In vitro polypeptide synthesis in brain. Arch Biochem Biophys 130:183-190.
14. Grof S (1963): Clinical and experimental study of central effects of adrenochrome. J Neuropsychiatry 5:33-50.
15. Hanson LO, Waters N, Winblad B, Gottfries C-G, Carlsson A (1994): Evidence for biochemical heterogeneity in schizophrenia: A multivariate study of monoaminergic indices in human post-mortal brain tissue. J Neural Transm GenSect 98:217-235.
16. Hastings TG (1995): Enzymatic oxidation of dopamine: The role of prostaglandin H synthase. J Neurochem 64:919-924.
17. Heacock RA, Powell WS (1973): Adrenochrome and related compounds. Prog Med Chem 9:296-339.
18. Hoffer A, Osmond H, Smythies JR (1954): Schizophrenia: A new approach. Part II. J Ment Sci. 100:29-45.
19. Holinger GD, Rosen GD, Galaburda AM (1995): Decreased neuronal density in supragranular layers of the human entorhinal cortex: Alteration in schizophrenia. Abst Soc Neurosci 21:238.
20. Kelsoe JR Jr, Tolbert LC, Crews EL, Smythies JR (1982). Kinetic evidence for decreased methionine adenosyltransferase activity in erythrocytes from schizophrenics. J Neurosci Res 8:99-103.
21. Levi RN, Waxman S (1975): Schizophrenia, epilepsy, cancer, methionine and folate metabolism. Lancet ii: 11-13.
22. Mattammal MB, Strong R, Lakshuri VM, Chung HD, Stephenson AH (1995): Prostaglandin H synthetase-mediated metabolism of dopamine: Implications for Parkinson's disease. J Neurochem 64:1645-1654.
23. Osmond H, Smythies J (1952): Schizophrenia; A new approach. J Ment Sci 98:309-320.
24. Pileblad E, Slivka A, Bratvold D, Cohen G (1988): Studies on the autoxidation of dopamine: Interaction with ascorbate. Arch Biochem Biophys 263:447-452.
25. Regland B, Andersson M, Abrahamsson L, Bagby J, Blennow K, Dyrehag LE, Gottfries C-G (1995): Homocysteinosis in the central nervous system in patients with fibromyalgia/chronic fatigue syndrome. Abstract at the International Conference on Homocysteine Metabolism, Dromoland Castle, Co. Clare, Ireland, July 2-6.
26. Regland B, Johansson BV, Grenfeldt B, Hjelmgren LT, Medhus M (1995): Homocysteinemia is a common feature of schizophrenia. J Neural Transm Gen Sect 100:1391-1398.
27. Rinkel M, Solomon AC (1957): Chemical theories of psychosis. J Clin Exp Psychopath 18:323-334.
28. Roberts RC, Gauther LA, Peretti F, Conley R, Lapidus B (1995): Structural pathology in schizophrenia: A postmortem ultra-structural study. Abst Soc Neurosci 21:237.
29. Sargent T III, Kusubov N, Taylor SE, Budinger TF (1992): Tracer kinetic evidence for abnormal methyl metabolism in schizophrenia. Biol Psychiatry 32:1078-1090.
30. Schwarz BE, Sem-Jacobsen C, Petersen MC (1956a): Effects of mescaline, LSD-25 and adrenochrome on depths electrograms in man. AMA Arch Neurol Psychiatry 75:579-587.
31. Schwarz BE, Wakim KG, Bickford RG, Lichtenheld FR (1956b): Behavioral and electroencephalographic effects of hallucinogenic drugs: changes in cats on intraventricular injection. AMA Arch Neurol Psychiatry 75:83-90.
32. Shafritz D, Goodwin F, Weissbach H (1969): Inhibition by aminochromes of in vitro polypeptide synthesis in Escherichia Coli. Arch Biochem Biophys. 134:478-485.
33. Smit NPM, Pavel S, Kammayer A, Westerhof W (1990): Determination of catechol O-methyltransferase activity in relation to melanin metabolism using high-performance liquid chromatography with fluorimetric detection. Anal Biochem 190:286-291.
34. Smythies, JR (1966): Recent advances in the biochemistry of schizophrenia. Guy's Gazette May 14, 2-7.
35. Smythies JR, Alarcon RD, Morere D, Monti JA, Steele M, Tolbert LC, Walter-Ryan WG (1986): Abnormalities of one-carbon metabolism in psychiatric disorders: Study of methionine adenosyltransferase kinetics and lipid composition of erythrocyte membranes. Biol Psychiatry 2:1391-1398.
36. Taborsky RG (1968): Indoxyl derivatives: Potential psychotropic metabolites. Int J Neuropharmacol 7:483-486.
37. Taubman G, Jantz H (1957): Untersuchung über die dem adrenochrom zugeschrieben psychotoxischen Wirkungen. Nervenartz 28:485-488.